ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9 | -74.3% | 66,895 | -2.0% | 0.00% | – |
| Q2 2023 | $35 | -27.1% | 68,295 | -10.9% | 0.00% | – |
| Q1 2023 | $48 | -4.0% | 76,620 | +0.0% | 0.00% | – |
| Q4 2022 | $50 | -100.0% | 76,595 | -0.7% | 0.00% | -100.0% |
| Q3 2022 | $133,000 | +31.7% | 77,122 | -6.4% | 0.00% | – |
| Q2 2022 | $101,000 | +83.6% | 82,412 | -2.4% | 0.00% | – |
| Q1 2022 | $55,000 | -40.2% | 84,412 | -0.3% | 0.00% | – |
| Q4 2021 | $92,000 | -41.8% | 84,652 | -2.6% | 0.00% | -100.0% |
| Q3 2021 | $158,000 | -31.0% | 86,879 | +0.0% | 0.00% | 0.0% |
| Q2 2021 | $229,000 | -25.6% | 86,869 | +1.6% | 0.00% | 0.0% |
| Q1 2021 | $308,000 | +39.4% | 85,462 | -2.6% | 0.00% | 0.0% |
| Q4 2020 | $221,000 | -21.4% | 87,787 | -21.2% | 0.00% | -50.0% |
| Q3 2020 | $281,000 | -16.1% | 111,432 | +9.0% | 0.00% | 0.0% |
| Q2 2020 | $335,000 | +14.7% | 102,247 | -14.3% | 0.00% | 0.0% |
| Q1 2020 | $292,000 | -48.4% | 119,267 | -0.6% | 0.00% | -50.0% |
| Q4 2019 | $566,000 | +31.3% | 119,951 | +19.1% | 0.00% | +33.3% |
| Q3 2019 | $431,000 | -18.7% | 100,701 | +10.8% | 0.00% | -25.0% |
| Q2 2019 | $530,000 | +68.3% | 90,914 | +11.0% | 0.00% | +33.3% |
| Q1 2019 | $315,000 | +108.6% | 81,914 | +1.4% | 0.00% | +200.0% |
| Q4 2018 | $151,000 | -42.1% | 80,776 | -1.0% | 0.00% | -50.0% |
| Q3 2018 | $261,000 | -32.9% | 81,551 | -36.6% | 0.00% | -50.0% |
| Q2 2018 | $389,000 | -22.5% | 128,692 | +0.4% | 0.00% | -20.0% |
| Q1 2018 | $502,000 | -10.8% | 128,175 | -5.7% | 0.01% | -16.7% |
| Q4 2017 | $563,000 | -59.6% | 135,955 | -40.0% | 0.01% | -62.5% |
| Q3 2017 | $1,392,000 | -6.2% | 226,629 | -5.0% | 0.02% | -15.8% |
| Q2 2017 | $1,484,000 | -12.1% | 238,662 | -10.4% | 0.02% | -13.6% |
| Q1 2017 | $1,689,000 | +25.9% | 266,366 | +6.2% | 0.02% | +10.0% |
| Q4 2016 | $1,342,000 | -14.8% | 250,756 | -10.3% | 0.02% | -28.6% |
| Q3 2016 | $1,575,000 | -37.2% | 279,703 | -17.3% | 0.03% | -57.6% |
| Q1 2016 | $2,509,000 | +10.2% | 338,190 | +23.4% | 0.07% | +11.9% |
| Q4 2015 | $2,277,000 | -12.5% | 273,955 | -5.1% | 0.06% | -19.2% |
| Q3 2015 | $2,601,000 | -99.9% | 288,727 | +6.5% | 0.07% | +7.4% |
| Q2 2015 | $3,253,140,000 | +127724.8% | 271,095 | +14.7% | 0.07% | +44.7% |
| Q1 2015 | $2,545,000 | -99.9% | 236,259 | -33.7% | 0.05% | +30.6% |
| Q4 2014 | $1,805,726,000 | +106.1% | 356,159 | +7.3% | 0.04% | +100.0% |
| Q3 2014 | $876,277,000 | -38.4% | 331,923 | -6.0% | 0.02% | -41.9% |
| Q2 2014 | $1,422,481,000 | -8.9% | 352,973 | +3.6% | 0.03% | -18.4% |
| Q1 2014 | $1,560,754,000 | +7.2% | 340,776 | +1.6% | 0.04% | 0.0% |
| Q4 2013 | $1,456,378,000 | +34.8% | 335,571 | +22.4% | 0.04% | +18.8% |
| Q3 2013 | $1,080,076,000 | +511.2% | 274,131 | +227.3% | 0.03% | +77.8% |
| Q2 2013 | $176,713,000 | – | 83,750 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 12,546,493 | $22,835,000 | 1.71% |
| MSD Partners, L.P. | 15,151,516 | $27,576,000 | 0.84% |
| MSD Partners, L.P. | 7,575,758 | $13,788,000 | 0.42% |
| CHIRON CAPITAL MANAGEMENT, LLC | 198,002 | $360,000 | 0.26% |
| Avidity Partners Management LP | 3,000,000 | $5,460,000 | 0.12% |
| Old West Investment Management, LLC | 211,513 | $384,000 | 0.10% |
| MAGNOLIA CAPITAL ADVISORS LLC | 103,239 | $188,000 | 0.07% |
| Virtus ETF Advisers LLC | 72,060 | $131,000 | 0.06% |
| ACT WEALTH MANAGEMENT, LLC | 34,454 | $91,000 | 0.06% |
| Allred Capital Management, LLC | 53,000 | $96,000 | 0.05% |